IKT Competitors & Alternatives
Compare Inhibikase Therapeutics Inc with similar stocks in the same industry
Biotechnology
IKT
Main Stock$2.01
Tradestie Score
64
Market Cap
$119.97M
Revenue Growth
-1.0%
Analyst Upside
+199.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.34
|
$304.12M | - | 54 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.17
|
$297.23M | - | 55 | Compare |
|
OMER
Omeros Corporation
|
$19.00
|
$281.75M | 11.2 | 53 | Compare |
|
DBVT
DBV Technologies S.A.
|
$10.41
|
$275.54M | - | 42 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.49
|
$275.13M | - | 40 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.03
|
$269.08M | 0.1 | 68 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$9.71
|
$265.45M | 19.3 | 53 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$26.62
|
$256.54M | - | 46 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$10.16
|
$240.89M | - | 58 | Compare |
More IKT Analysis
Data updated: Oct 05, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry